Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Mosekilde

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Clinical Endocrinology|April 16, 2008
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methodsSigne Engkjaer Christensen, Peter H Nissen, Peter Vestergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2013
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatmentTanja Sikjaer, Anne Kristine Amstrup, Lars Rolighed, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Clinical Endocrinology|November 17, 2009
Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disordersPeter H Nissen, Signe E Christensen, Andrew Wallace, et al.
Langenbeck'S Archives of Surgery|November 8, 2012
BMD improvements after operation for primary hyperparathyroidismLars Rolighed, Peter Vestergaard, Lene Heickendorff, et al.
Calcified Tissue International|July 26, 2011
Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative studyTroels Isaksen, Christian Stoltz Nielsen, Signe Engkjær Christensen, et al.
Calcified Tissue International|December 14, 2004
Fracture risk in perimenopausal women treated with beta-blockersLars Rejnmark, Peter Vestergaard, Moustapha Kassem, et al.
The American Journal of Clinical Nutrition|June 21, 2013
Cobalamin and haptocorrin in human milk and cobalamin-related variables in mother and child: a 9-mo longitudinal studyEva Greibe, Dorte L Lildballe, Súsanna Streym, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 24, 2011
Identification of rare and frequent variants of the CASR gene by high-resolution meltingPeter H Nissen, Signe E Christensen, Søren A Ladefoged, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Clinical Endocrinology|April 16, 2008
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methodsSigne Engkjaer Christensen, Peter H Nissen, Peter Vestergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2013
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatmentTanja Sikjaer, Anne Kristine Amstrup, Lars Rolighed, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Clinical Endocrinology|November 17, 2009
Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disordersPeter H Nissen, Signe E Christensen, Andrew Wallace, et al.
Langenbeck'S Archives of Surgery|November 8, 2012
BMD improvements after operation for primary hyperparathyroidismLars Rolighed, Peter Vestergaard, Lene Heickendorff, et al.
Calcified Tissue International|July 26, 2011
Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative studyTroels Isaksen, Christian Stoltz Nielsen, Signe Engkjær Christensen, et al.
Calcified Tissue International|December 14, 2004
Fracture risk in perimenopausal women treated with beta-blockersLars Rejnmark, Peter Vestergaard, Moustapha Kassem, et al.
The American Journal of Clinical Nutrition|June 21, 2013
Cobalamin and haptocorrin in human milk and cobalamin-related variables in mother and child: a 9-mo longitudinal studyEva Greibe, Dorte L Lildballe, Súsanna Streym, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 24, 2011
Identification of rare and frequent variants of the CASR gene by high-resolution meltingPeter H Nissen, Signe E Christensen, Søren A Ladefoged, et al.
Pageof 16